Zobrazeno 1 - 10
of 620
pro vyhledávání: '"PTOV1"'
Autor:
Xie, Si-An a, b, 1, Zhang, Wen a, 1, Du, Feng a, b, Liu, Si a, b, Ning, Ting-Ting a, b, Zhang, Nan a, b, Zhang, Shu-Tian a, b, ⁎⁎, Zhu, Sheng-Tao a, b, ⁎
Publikováno v:
In Heliyon 30 August 2024 10(16)
Autor:
Si-An Xie, Wen Zhang, Feng Du, Si Liu, Ting-Ting Ning, Nan Zhang, Shu-Tian Zhang, Sheng-Tao Zhu
Publikováno v:
Heliyon, Vol 10, Iss 16, Pp e36017- (2024)
Background: Colorectal cancer is a predominant contributor to global cancer-related morbidity and mortality. The oncogene PTOV1 has been linked to various human malignancies, yet its specific role in CRC pathogenesis requires further elucidation. Met
Externí odkaz:
https://doaj.org/article/01035808dd8a429f9634a0f8cae66db5
Autor:
XIE Si-an, CHEN Yi-yang, XU Jun-xuan, NING Ting-ting, ZHANG Nan, ZHU Sheng-tao, ZHANG Shu-tian
Publikováno v:
Jichu yixue yu linchuang, Vol 42, Iss 8, Pp 1176-1181 (2022)
Objective To analyze the effect of over-expression of prostate tumor 1 (PTOV1) on the prognosis of colorectal cancer (CRC) based on bioinformatics, and to demonstrate the effect of PTOV1 on the proliferation of CRC cells. Methods Combined with bioinf
Externí odkaz:
https://doaj.org/article/6646d72db26745248a835ccfe2d3d012
Autor:
Liu F; Department of Pathophysiology, School of Basic Medical Sciences, Shanxi Medical University Jinzhong 030600, Shanxi, China., Zhang Y; Department of Pathophysiology, School of Basic Medical Sciences, Shanxi Medical University Jinzhong 030600, Shanxi, China., Wu J; Department of Thoracic Surgery, The First Hospital of Shanxi Medical University Taiyuan 030001, Shanxi, China., Huo YK; Department of Thoracic Surgery, The First Hospital of Shanxi Medical University Taiyuan 030001, Shanxi, China.
Publikováno v:
American journal of translational research [Am J Transl Res] 2024 Nov 15; Vol. 16 (11), pp. 7107-7114. Date of Electronic Publication: 2024 Nov 15 (Print Publication: 2024).
Autor:
Karna, Shibendra Kumar Lal1, Ahmad, Faiz1, Lone, Bilal Ahmad1, Pokharel, Yuba Raj1 yrp@sau.ac.in
Publikováno v:
PLoS ONE. 5/13/2019, Vol. 14 Issue 5, p1-17. 17p.
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss , Pp 499-507 (2021)
Chemotherapy resistance is a bottleneck for ovarian cancer treatment; therefore, revealing its regulatory mechanism is critical. In the present study, we found that prostate tumor overexpressed-1 (PTOV1) was upregulated significantly in ovarian cance
Externí odkaz:
https://doaj.org/article/271cbd1e65074acf9b9c73f45cfff49d
Autor:
Yang, Qi1,2, Lin, Huanxin1,3, Wu, Shu1,4, Lei, Fangyong1,4, Zhu, Xi1,2, Song, Libing1,4, Hong, Minghuang1,5, Guo, Ling1,2 guoling1423@163.com
Publikováno v:
PLoS ONE. 8/25/2015, Vol. 10 Issue 8, p1-13. 13p.
Autor:
Shen, Hongwei, Liao, Bing, Wan, Zhiyong, Zhao, Yunhe, You, Zeshan, Liu, Jun, Lan, Jin, He, Shanyang
Publikováno v:
In Molecular Therapy - Oncolytics 26 March 2021 20:499-507
Autor:
Zhiqiang Wu, Zhuang Liu, Xiangli Jiang, Zeyun Mi, Maobin Meng, Hui Wang, Jinlin Zhao, Boyu Zheng, Zhiyong Yuan
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-14 (2019)
Abstract Background Prostate tumor over expressed gene 1 (PTOV1) has been reported as an oncogene in several human cancers. However, the clinical significance and biological role of PTOV1 remain elusive in non-small cell lung cancer (NSCLC). Methods
Externí odkaz:
https://doaj.org/article/ab74c376bafd46faa404301fb0fe9fc5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.